<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39434006</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>COVID-19 vaccine hesitancy in Ethiopia: a latent class analysis.</ArticleTitle><Pagination><StartPage>2894</StartPage><MedlinePgn>2894</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2894</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-024-20359-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Despite evidence demonstrating the effectiveness of the COVID-19 vaccine, vaccine hesitancy has emerged as a major challenge for vaccine uptake. The objective of this study was to classify latent typologies of vaccine hesitant adults in Ethiopia and identify predictors of the latent classes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We employed a cross-sectional household survey among 1,112 individuals aged 18 and above who were partially vaccinated (one dose) or not vaccinated at the time of the survey. Data was collected in August 2022. We collected information on participant socio-demographics, COVID-19 knowledge, prevention practices, disease history, and vaccine hesitancy. Latent class analysis was used to classify individuals into categories of vaccine hesitancy. We conducted multinomial logistic regression to test the associations between latent typologies and different demographic and COVID-19 related characteristics of study participants.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Using latent class analysis we found a four-class solution for vaccine hesitancy typologies. The identified classes were strong vaccine acceptors (30%); vaccine acceptors with some concerns (7%); vaccine sceptics (13%); and vaccine rejectors (50%). In adjusted models with vaccine sceptics as the referent group, those with high COVID-19 vaccine knowledge were significantly more likely to belong to the strong vaccine acceptors class compared to those with low vaccine knowledge (adj. RRR: 17.36, 95% CI: 10.94-27.55). Better COVID-19 prevention practices were also significantly associated with belonging to the vaccine acceptors with some concerns class than the vaccine sceptics class (adj. RRR: 2.13, 95% CI: 1.09-4.16). Those who had one dose of the COVID-19 vaccine were significantly more likely to belong in the vaccine acceptors class than the vaccine sceptics class compared to those who had no dose (adj. RRR: 6.82, 95% CI: 3.06-15.21).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Half of the study participants were in the vaccine rejectors class. Individuals in the vaccine sceptics and rejector classes evidenced lower vaccine knowledge and worse COVD-19 prevention practices and were less likely to have been partially vaccinated. Future program interventions should focus on improving knowledge around the vaccine, decrease rumors and misconceptions, and target individuals who may be more amenable to changing their vaccination attitudes or behaviors like vaccine sceptics or acceptors with some concerns.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Anteneh</LastName><ForeName>Aderaw</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Population Services International, Addis Ababa, Ethiopia. aderaw.ama@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Getachew</LastName><ForeName>Anteneh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Population Services International, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kenera</LastName><ForeName>Misael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Population Services International, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salim</LastName><ForeName>Amel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Population Services International, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kedir</LastName><ForeName>Fethia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Population Services International, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belayihun</LastName><ForeName>Bekele</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Population Services International, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Felker-Kantor</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Population Services International, Washington, DC, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005002" MajorTopicYN="N" Type="Geographic">Ethiopia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000088823" MajorTopicYN="Y">Vaccination Hesitancy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077272" MajorTopicYN="Y">Latent Class Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Ethiopia</Keyword><Keyword MajorTopicYN="N">Latent class analysis</Keyword><Keyword MajorTopicYN="N">Vaccine hesitancy</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>7</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>23</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39434006</ArticleId><ArticleId IdType="pmc">PMC11492752</ArticleId><ArticleId IdType="doi">10.1186/s12889-024-20359-2</ArticleId><ArticleId IdType="pii">10.1186/s12889-024-20359-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Platto S, Wang Y, Zhou J, Carafoli E. History of the COVID-19 pandemic: origin, explosion, worldwide spreading. Biochem Biophys Res Commun. 2021;538:14–23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834510</ArticleId><ArticleId IdType="pubmed">33199023</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens DM, Breman JG, Calisher CH, Doherty PC, Hahn BH, Keusch GT, et al. The origin of COVID-19 and why it matters. Am J Trop Med Hyg. 2020;103:955–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7470595</ArticleId><ArticleId IdType="pubmed">32700664</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner AL, Porth JM, Wu Z, Boulton ML, Finlay JM, Kobayashi LC. Vaccine hesitancy during the COVID-19 pandemic: a latent class analysis of Middle-aged and older US adults. J Community Health. 2022;47:408–15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8788403</ArticleId><ArticleId IdType="pubmed">35079933</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO). WHO Health Emergency Dashboard WHO (COVID-19) Homepage. 2022. https://covid19.who.int/region/afro/country/et</Citation></Reference><Reference><Citation>EPHI. COVID-19. https://covid19.ephi.gov.et/covid-19/</Citation></Reference><Reference><Citation>Denano T. COVID-19’s effects on Macroeconomic indicators in Ethiopia: systematic review of Articles. ClinicoEconomics Outcomes Res. 2023;15:573–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10364812</ArticleId><ArticleId IdType="pubmed">37492201</ArticleId></ArticleIdList></Reference><Reference><Citation>Daher-Nashif S, Al-Anany R, Ali M, Erradi K, Farag E, Abdallah AM, et al. COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity. Arch Virol. 2022;167:1773–83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9208258</ArticleId><ArticleId IdType="pubmed">35723757</ArticleId></ArticleIdList></Reference><Reference><Citation>She J, Hou D, Chen C, Bi J, Song Y. Challenges of vaccination and herd immunity in COVID-19 and management strategies. Clin Respiratory J. 2022;16:708–16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9539035</ArticleId><ArticleId IdType="pubmed">36172975</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO). Ten threats to global health in 2019. 2019. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019</Citation></Reference><Reference><Citation>Sudaxshina Murdan. NA&amp; DA-O. How to address vaccine hesitancy. Pharm J, PJ,. 2021;306.</Citation></Reference><Reference><Citation>Tesfaye A, Tamene B, Alemeshet D, Abe H, Tesfa N, Gedion S et al. COVID-19 vaccine hesitancy in Addis Ababa, Ethiopia: a mixed-methods study. medRxiv. 2021;:2021.02.25.21252443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9152622</ArticleId><ArticleId IdType="pubmed">35636790</ArticleId></ArticleIdList></Reference><Reference><Citation>Zewude B, Habtegiorgis T. Willingness to take COVID-19 vaccine among people most at risk of exposure in Southern Ethiopia. Pragmat Obs Res. 2021;12:37–47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8166351</ArticleId><ArticleId IdType="pubmed">34079423</ArticleId></ArticleIdList></Reference><Reference><Citation>Mekonnen BD, Mengistu BA. COVID-19 vaccine acceptance and its associated factors in Ethiopia: a systematic review and meta-analysis. Clin Epidemiol Glob Health. 2022;14:101001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8898789</ArticleId><ArticleId IdType="pubmed">35284688</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper S, van Rooyen H, Wiysonge CS. COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines? Expert Rev Vaccines. 2021;20:921–33.</Citation><ArticleIdList><ArticleId IdType="pubmed">34252336</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Su X, Xiao W, Wang H, Si M, Wang W, et al. COVID-19 vaccine hesitancy among different population groups in China: a national multicenter online survey. BMC Infect Dis. 2022;22:1–12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8845236</ArticleId><ArticleId IdType="pubmed">35164700</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegegne MD, Girma S, Mengistu S, Mesfin T, Adugna T, Kokeb M et al. Willingness to receive COVID-19 vaccine and associated factors among adult chronic patients. A cross-sectional study in Northwest Ethiopia. PLoS ONE. 2022;17 7 July.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9275707</ArticleId><ArticleId IdType="pubmed">35819959</ArticleId></ArticleIdList></Reference><Reference><Citation>Liga AD, Jabir YN, Bacha RH. COVID-19 vaccine acceptance and adherence to non-pharmaceutical interventions among employees of public transportations company in Addis Ababa, Ethiopia. Hum Vaccin Immunother. 2023;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10026860</ArticleId><ArticleId IdType="pubmed">36880671</ArticleId></ArticleIdList></Reference><Reference><Citation>Niguse S, Gebremariam S, Terefa DR, Biset Y, Mekasha E, Meskele K. Assessment of COVID-19 vaccine take-up and its predictors among healthcare professionals in public hospitals, Addis Ababa, Ethiopia: facility-based cross-sectional study. Hum Vaccin Immunother. 2023;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10012945</ArticleId><ArticleId IdType="pubmed">36746745</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolossa T, Fetensa G, Ayala D, Wakuma B. Health professionals’ COVID-19 vaccine acceptance and associated factors in Wollega University referral hospital, Western Ethiopia: a cross-sectional study. Hum Vaccin Immunother. 2022;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9302494</ArticleId><ArticleId IdType="pubmed">35608849</ArticleId></ArticleIdList></Reference><Reference><Citation>De Waure C, Shakeel S, Martin P, Agyekum W, Sertsu A. Acceptance of COVID-19 vaccine and associated factors among health care workers at public hospitals in Eastern Ethiopia using the health belief model. Front Public Health 10:957721 doi: 103389/fpubh2022957721. 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9683340</ArticleId><ArticleId IdType="pubmed">36438218</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan H-F, Mekonen E, Bhattacharya M, Asmare Adella G. Knowledge, attitude, and intention to accept COVID-19 vaccine among patients with chronic diseases in southern Ethiopia: Multi-center study. Front Public Health 10:917925 doi: 103389/fpubh2022917925. 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9557055</ArticleId><ArticleId IdType="pubmed">36249216</ArticleId></ArticleIdList></Reference><Reference><Citation>Getachew T, Negash A, Degefa M, Lami M, Balis B, Debela A, et al. COVID-19 vaccine acceptance and associated factors among adult clients at public hospitals in eastern Ethiopia using the health belief model: multicentre cross-sectional study. BMJ Open. 2023;13:e070551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10039978</ArticleId><ArticleId IdType="pubmed">36958789</ArticleId></ArticleIdList></Reference><Reference><Citation>Abay ES, Belew MD, Ketsela BS, Mengistu EE, Getachew LS, Teferi YA et al. Assessment of attitude towards COVID-19 vaccine and associated factors among clinical practitioners in Ethiopia: a cross-sectional study. PLoS ONE. 2022;17 6 June.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9202929</ArticleId><ArticleId IdType="pubmed">35709076</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammed R, Nguse TM, Habte BM, Fentie AM, Gebretekle GB. COVID-19 vaccine hesitancy among Ethiopian healthcare workers. PLoS ONE. 2021;16(12 December):1–15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8682893</ArticleId><ArticleId IdType="pubmed">34919597</ArticleId></ArticleIdList></Reference><Reference><Citation>Abebe H, Shitu S, Mose A. Understanding of COVID-19 vaccine knowledge, attitude, acceptance, and determinates of COVID-19 vaccine acceptance among adult population in Ethiopia. Infect Drug Resist. 2021;14:2015–25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8179743</ArticleId><ArticleId IdType="pubmed">34103948</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner AL, Masters NB, Domek GJ, Mathew JL, Sun X, Asturias EJ et al. Comparisons of vaccine hesitancy across five low- and middle-income countries. Vaccines (Basel). 2019;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6963484</ArticleId><ArticleId IdType="pubmed">31635270</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera YA, Wagner AL, Mekonen EB, Carlson BF, Boulton ML. Predictors and barriers to full vaccination among children in Ethiopia. Vaccines (Basel). 2018;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6027055</ArticleId><ArticleId IdType="pubmed">29642596</ArticleId></ArticleIdList></Reference><Reference><Citation>Németh R, Hungary RN. Respondent selection within the Household-A modification of the Kish Grid of the International Program Committee View project Respondent selection within the household-A modification of the Kish grid. 2018.</Citation></Reference><Reference><Citation>Gallè F, Sabella EA, Roma P, De Giglio O, Caggiano G, Tafuri S et al. Knowledge and acceptance of COVID-19 vaccination among undergraduate students from central and southern Italy. Vaccines (Basel). 2021;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8230551</ArticleId><ArticleId IdType="pubmed">34200835</ArticleId></ArticleIdList></Reference><Reference><Citation>Elyeli K, Bebiş H. The COVID-19 vaccine knowledge and attitude scale: a methodological study. Cyprus J Med Sci. 2022;7:312–20.</Citation></Reference><Reference><Citation>Aklil MB, Temesgan WZ. Knowledge and attitude towards COVID-19 vaccination and Associated Factors among College students in Northwest Ethiopia,2021. Health Serv Res Manag Epidemiol. 2022;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9073108</ArticleId><ArticleId IdType="pubmed">35528024</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong MC, Duong BT, Nguyen HT, Nguyen Thi Quynh T, Nguyen DP. Knowledge about COVID-19 vaccine and vaccination in Vietnam: a population survey. J Am Pharmacists Association. 2022;62:1197–e12054.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8767973</ArticleId><ArticleId IdType="pubmed">35151581</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman D, Loe BS, Chadwick A, Vaccari C, Waite F, Rosebrock L et al. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol Med. 2021. 10.1017/S0033291720005188</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7804077</ArticleId><ArticleId IdType="pubmed">33305716</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubé E, MacDonald NE. COVID-19 vaccine hesitancy. Nat Rev Nephrol. 2022;18:409–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9004449</ArticleId><ArticleId IdType="pubmed">35414006</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesele M. Covid-19 vaccination acceptance and its associated factors in Sodo town, wolaita zone, southern ethiopia: cross-sectional study. Infect Drug Resist. 2021;14:2361–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238544</ArticleId><ArticleId IdType="pubmed">34194232</ArticleId></ArticleIdList></Reference><Reference><Citation>Mose A, Wasie A, Shitu S, Haile K, Timerga A, Melis T et al. Determinants of COVID-19 vaccine acceptance in Ethiopia: a systematic review and meta-analysis. PLoS ONE. 2022;17 6 June.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9165773</ArticleId><ArticleId IdType="pubmed">35657814</ArticleId></ArticleIdList></Reference><Reference><Citation>Tadesse TA, Antheneh A, Teklu A, Teshome A, Alemayehu B, Belayneh A, et al. COVID-19 vaccine hesitancy and its reasons in Addis Ababa, Ethiopia: a cross-sectional study. Ethiop J Health Sci. 2022;32:1061–70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9692159</ArticleId><ArticleId IdType="pubmed">36475258</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackah BBB, Woo M, Stallwood L, Fazal ZA, Okpani A, Ukah UV et al. COVID-19 vaccine hesitancy in Africa: a scoping review. Global Health Res Policy. 2022;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9294808</ArticleId><ArticleId IdType="pubmed">35850783</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh K, Lima G, Cha M, Cha C, Kulshrestha J, Ahn YY et al. Misinformation, believability, and vaccine acceptance over 40 countries: takeaways from the initial phase of the COVID-19 infodemic. PLoS ONE. 2022;17 2 February.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8827463</ArticleId><ArticleId IdType="pubmed">35139117</ArticleId></ArticleIdList></Reference><Reference><Citation>Moola S, Gudi N, Nambiar D, Dumka N, Ahmed T, Sonawane IR et al. A rapid review of evidence on the determinants of and strategies for COVID-19 vaccine acceptance in low- and middle-income countries. J Glob Health. 2021;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8645216</ArticleId><ArticleId IdType="pubmed">34912550</ArticleId></ArticleIdList></Reference><Reference><Citation>Muluneh MD, Negash K, Tsegaye S, Abera Y, Tadesse D, Abebe S et al. COVID-19 knowledge, attitudes, and Vaccine Hesitancy in Ethiopia: A Community-based cross-sectional study. Vaccines (Basel). 2023;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10140841</ArticleId><ArticleId IdType="pubmed">37112686</ArticleId></ArticleIdList></Reference><Reference><Citation>Oche OM, Adamu H, Yahaya M, Illo HG, Danmadami AM, Ijapa A et al. Perception and willingness to accept COVID-19 vaccines: a cross-sectional survey of the general population of Sokoto State, Nigeria. PLoS ONE. 2022;17 12 December.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714919</ArticleId><ArticleId IdType="pubmed">36454892</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali M, Uddin Z, Banik PC, Hegazy FA, Zaman S, Ambia ASM, et al. Knowledge, attitude, practice, and fear of COVID-19: an online-based cross-cultural study. Int J Ment Health Addict. 2023;21:1025–40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8404540</ArticleId><ArticleId IdType="pubmed">34483782</ArticleId></ArticleIdList></Reference><Reference><Citation>Qalati SA, Ostic D, Fan M, Dakhan SA, Vela EG, Zufar Z, et al. The General Public Knowledge, attitude, and practices regarding COVID-19 during the Lockdown in Asian developing countries. Int Q Community Health Educ. 2021. 10.1177/0272684X211004945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8058537</ArticleId><ArticleId IdType="pubmed">33832371</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>